Crossmark

Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial

Crossref DOI link: https://doi.org/10.1038/s41398-023-02404-7

Published Online: 2023-04-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Spreer, Maik https://orcid.org/0000-0001-8436-8520
Grählert, Xina

Klut, Ina-Maria

Al Hamdan, Feras

Sommer, Wolfgang H. https://orcid.org/0000-0002-5903-6521
Plawecki, Martin H.

O’Connor, Sean

Böttcher, Michael

Sauer, Cathrin

Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Zimmermann, Ulrich S. https://orcid.org/0000-0001-7900-4992
Funding

Funding for this research was provided by:

Bundesministerium für Bildung und Forschung (01ZX1311H)

Bundesministerium für Bildung und Forschung (01ZX1611H)

Bundesministerium für Bildung und Forschung (01ZX1311H)

Bundesministerium für Bildung und Forschung (01ZX1611H)

Bundesministerium für Bildung und Forschung (01ZX1311H)

Bundesministerium für Bildung und Forschung (01ZX1611H)

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (P60 AA07611)

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01 AA027236)

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (P60 AA07611)

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
License Information

Text and Data Mining valid from 2023-04-05

Version of Record valid from 2023-04-05
More Information

Article History

Received: 25 August 2022

Revised: 17 March 2023

Accepted: 20 March 2023

First Online: 5 April 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below